233 related articles for article (PubMed ID: 27836119)
1. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.
Kawashiro S; Yamada S; Okamoto M; Ohno T; Nakano T; Shinoto M; Shioyama Y; Nemoto K; Isozaki Y; Tsuji H; Kamada T
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1212-1221. PubMed ID: 29907490
[TBL] [Abstract][Full Text] [Related]
3. Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702".
Kawamura H; Kubo N; Sato H; Mizukami T; Katoh H; Ishikawa H; Ohno T; Matsui H; Ito K; Suzuki K; Nakano T;
BMC Cancer; 2020 Jan; 20(1):75. PubMed ID: 32000716
[TBL] [Abstract][Full Text] [Related]
4. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum.
Shinoto M; Yamada S; Okamoto M; Shioyama Y; Ohno T; Nakano T; Nemoto K; Isozaki Y; Kawashiro S; Tsuji H; Kamada T
Radiother Oncol; 2019 Mar; 132():236-240. PubMed ID: 30360998
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.
Nomiya T; Tsuji H; Maruyama K; Toyama S; Suzuki H; Akakura K; Shimazaki J; Nemoto K; Kamada T; Tsujii H;
Br J Cancer; 2014 May; 110(10):2389-95. PubMed ID: 24722181
[TBL] [Abstract][Full Text] [Related]
6. Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
Okada T; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):968-72. PubMed ID: 22898380
[TBL] [Abstract][Full Text] [Related]
7. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
8. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.
Akakura K; Tsuji H; Suzuki H; Ichikawa T; Ishikawa H; Okada T; Kamada T; Harada M; Tsujii H; Shimazaki J
Jpn J Clin Oncol; 2014 Apr; 44(4):360-5. PubMed ID: 24585931
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group.
Iwata H; Ishikawa H; Takagi M; Okimoto T; Murayama S; Akimoto T; Wada H; Arimura T; Sato Y; Araya M; Mizoe JE; Gosho M; Nakamura K; Shirato H; Sakurai H
Cancer Med; 2018 Mar; 7(3):677-689. PubMed ID: 29441697
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment.
Yonai S; Matsufuji N; Akahane K
Phys Med; 2018 Jul; 51():48-55. PubMed ID: 29699921
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter Study of Carbon-Ion Radiation Therapy for Head and Neck Adenocarcinoma.
Saitoh JI; Koto M; Demizu Y; Suefuji H; Ohno T; Tsuji H; Okimoto T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):442-449. PubMed ID: 28871995
[TBL] [Abstract][Full Text] [Related]
14. Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
Radiother Oncol; 2023 Jun; 183():109640. PubMed ID: 36990390
[TBL] [Abstract][Full Text] [Related]
15. Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan.
Nihei K; Ogino T; Ishikura S; Kawashima M; Nishimura H; Arahira S; Onozawa M
Jpn J Clin Oncol; 2005 Dec; 35(12):745-52. PubMed ID: 16314345
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
[TBL] [Abstract][Full Text] [Related]
17. Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y; Katoh H; Kano K; Anno W; Tsuchida K; Mizoguchi N; Serizawa I; Yoshida D; Kamada T
Radiat Oncol; 2020 May; 15(1):127. PubMed ID: 32460889
[TBL] [Abstract][Full Text] [Related]
18. Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life.
Ishikawa H; Katoh H; Kaminuma T; Kawamura H; Ito K; Matsui H; Hirato J; Shimizu N; Takezawa Y; Tsuji H; Suzuki K; Ohno T; Nakano T;
Anticancer Res; 2015 Oct; 35(10):5559-66. PubMed ID: 26408726
[TBL] [Abstract][Full Text] [Related]
19. A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer.
Shinoto M; Terashima K; Suefuji H; Matsunobu A; Toyama S; Fukunishi K; Shioyama Y
Radiother Oncol; 2018 Nov; 129(2):333-339. PubMed ID: 30224179
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
